Psychology & Intimacy Unlocking Ketamine’s Antidepressant Secrets: Japanese Study Reveals Brain Receptor Dynamics April 25, 2026 Rebecca Shoemaker Major depressive disorder (MDD) stands as a formidable global health crisis, contributing significantly to the worldwide burden of disability. Affecting an estimated 280 million people globally, MDD’s impact extends beyond…
Psychology & Intimacy Unraveling Ketamine’s Mysteries: Japanese Study Reveals How Brain Receptors Respond to Treatment-Resistant Depression Therapy April 18, 2026 Rebecca Shoemaker Major depressive disorder (MDD) stands as a formidable global health challenge, recognized as a primary contributor to disability worldwide. For a significant portion of individuals diagnosed with depression, the efficacy…
Psychology & Intimacy Japanese Scientists Uncover Key Mechanism Behind Ketamine’s Rapid Antidepressant Effects Through Advanced Brain Imaging April 10, 2026 Rebecca Shoemaker Major depressive disorder (MDD) stands as a significant global health crisis, recognized as a primary contributor to disability worldwide. Despite the availability of various therapeutic interventions, a substantial portion of…
Psychology & Intimacy Unraveling the Mystery: Japanese Study Illuminates Ketamine’s Brain Mechanism for Treatment-Resistant Depression April 2, 2026 Rebecca Shoemaker Major depressive disorder (MDD) stands as a formidable global health crisis, recognized as a primary driver of disability worldwide. Despite advancements in psychiatric care, a significant subset of individuals, estimated…
Psychology & Intimacy Unraveling Ketamine’s Mysteries: Landmark Study Illuminates Brain Receptor Activity in Treatment-Resistant Depression March 26, 2026 Rebecca Shoemaker Major depressive disorder (MDD) represents a profound and pervasive global health challenge, standing as a leading contributor to worldwide disability. The debilitating nature of this condition is amplified by the…
Psychology & Intimacy Unlocking the Mystery of Ketamine’s Rapid Antidepressant Action: Japanese Study Visualizes Brain Receptor Changes in Treatment-Resistant Depression March 19, 2026 Rebecca Shoemaker Major depressive disorder (MDD) casts a long shadow over global public health, recognized as a primary driver of disability worldwide. For a significant portion of individuals diagnosed with depression, approximately…
